Tamayo Louis Edward
SEC CIK 2083206 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | CFO | 92.9K | — | $41.0K | 5 | 2025-08-29 | 2026-08-18 |
Most active insiders at LXEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| 2 | Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| 3 | Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| 4 | Tamayo Louis Edward | CFO | — | $41.0K |
| 5 | See Tai Sandi | Chief Development Off | — | $38.4K |
| 6 | Robertson Jenny | CLO | — | $36.6K |
| 7 | Adler Eric | Chief Medical Off | — | $36.0K |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 17:00 | 2026-08-18 | LXEO | Lexeo Therapeutics, Inc. | Tamayo Louis Edward | CFO | S - Sale | $4.91 | -4,117 | 92.9K | -4% | -$20.2K | |
| 2026-07-01 18:49 | 2026-06-29 | LXEO | Lexeo Therapeutics, Inc. | Tamayo Louis Edward | CFO | A - Grant | $0.00 | +12.0K | 101.7K | +13% | $0 | |
| 2026-07-01 18:49 | 2026-07-01 | LXEO | Lexeo Therapeutics, Inc. | Tamayo Louis Edward | CFO | S - Sale | $4.49 | -4,641 | 97.0K | -5% | -$20.8K | |
| D | 2026-02-06 | 2026-02-04 | LXEO | Lexeo Therapeutics, Inc. | Tamayo Louis Edward | CFO | A - Grant | $0.00 | +44.7K | 89.7K | +99% | $0 |
| D | 2025-09-03 | 2025-08-29 | LXEO | Lexeo Therapeutics, Inc. | Tamayo Louis Edward | CFO | A - Grant | $0.00 | +45.0K | 45.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations